D.E. Shaw & Co’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,343
Closed -$158K 5361
2021
Q2
$158K Buy
1,343
+419
+45% +$54.8K ﹤0.01% 4491
2021
Q1
$175K Sell
924
-1,086
-54% -$190K ﹤0.01% 3874
2020
Q4
$283K Buy
2,010
+100
+5% +$14.8K ﹤0.01% 3622
2020
Q3
$313K Buy
+1,910
New +$340K ﹤0.01% 3428
2016
Q3
Sell
-319
Closed -$33K 3611
2016
Q2
$33K Sell
319
-2,281
-88% -$163K ﹤0.01% 3299
2016
Q1
$197K Buy
2,600
+976
+60% +$57.6K ﹤0.01% 3195
2015
Q4
$129K Buy
1,624
+51
+3% +$25.1K ﹤0.01% 3647
2015
Q3
$1.06M Buy
1,573
+1,321
+524% +$940K ﹤0.01% 2566
2015
Q2
$168K Buy
+252
New +$167K ﹤0.01% 3604
2015
Q1
Sell
-166
Closed -$88K 4107
2014
Q4
$88K Buy
166
+45
+37% +$22.5K ﹤0.01% 3913
2014
Q3
$72K Buy
+121
New +$83.7K ﹤0.01% 4007
2014
Q2
Sell
-579
Closed -$455K 4612
2014
Q1
$455K Sell
579
-1,509
-72% -$1.23M ﹤0.01% 3676
2013
Q4
$1.61M Buy
2,088
+1,051
+101% +$793K ﹤0.01% 2734
2013
Q3
$795K Buy
1,037
+753
+265% +$619K ﹤0.01% 3242
2013
Q2
$246K Buy
+284
New +$240K ﹤0.01% 3674

Other funds holding MTEM

D.E. Shaw & Co's MTEM Position: Q3 2021 in Review

D.E. Shaw & Co sold out of Molecular Templates, Inc. (MTEM) in Q3 2021, closing a stake of 1,343 shares — an estimated $158K sold.

D.E. Shaw & Co first reported a position in MTEM in Q2 2013 and held it in 15 quarters. The position peaked at $1.61M in Q4 2013. 86 funds tracked by Wall St. Rank hold MTEM as of Q3 2021.

  • D.E. Shaw & Co reported no remaining Molecular Templates, Inc. position as of Q3 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,343 Molecular Templates, Inc. shares in Q3 2021, an estimated $158K.
  • D.E. Shaw & Co first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 15 quarters.
  • D.E. Shaw & Co's Molecular Templates, Inc. position peaked at $1.61M in Q4 2013.
  • 86 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.